| Literature DB >> 29361820 |
Joo Eun Lee1,2, Sang Ah Lee1,2, Tae Hyun Kim2,3, Sohee Park3, Yoon Soo Choy1,2, Yeong Jun Ju1,2, Eun-Cheol Park2,4.
Abstract
PURPOSE: The aim of this study was to estimate the burden of breast cancer that can be attributed to rapid lifestyle changes in South Korea in 2013-2030.Entities:
Keywords: Breast neoplasms; Lifestyle; Republic of Korea; Risk factors
Mesh:
Year: 2018 PMID: 29361820 PMCID: PMC6192937 DOI: 10.4143/crt.2017.162
Source DB: PubMed Journal: Cancer Res Treat ISSN: 1598-2998 Impact factor: 4.679
Data sources and Global Burden of Disease Study Group formulae
| Measure | Study |
|---|---|
| YLL= | |
| Average age at onset for each age cohort (a) | Average age |
| Discount rate (r=0.03) | [ |
| Age-weighting constants (β=0.04, K=1.00, C=0.1658) | [ |
| Mortalities (M) | [ |
| Standard life expectancy at the age of death (L) | [ |
| YLD= | |
| Incidences (I) | [ |
| Disability weights (DW=0.37) | [ |
| Average age at onset for each age cohort (a) | [ |
| Discount rate (r=0.03) | [ |
| Age-weighting constants (β=0.04, K=1.00, C=0.1658) | [ |
| Expected duration of disability (L) | [ |
Fig. 1.Projected age-specific incidence rates of breast cancer per 100,000 women in South Korea from 2000 to 2030.
Fig. 2.Projected age-specific mortality rates of breast cancer per 100,000 women in South Korea from 2000 to 2030.
Relative risks and changes in the prevalence (%) of breast cancer risk factors according to lifestyle changes from 1998 to 2015
| Relative risk (95% CI) | Prevalence (%) | |||
|---|---|---|---|---|
| 1998 | 2015 | 2030 | ||
| ≤ 23 | 1.00 | 13.8 | 4.9 | - |
| 24-30 | 1.13 (0.98-1.32) | 66.7 | 36.5 | - |
| ≥ 31 | 1.27 (0.98-1.66) | 9.5 | 48.6 | - |
| Never | 1.03 (0.87-1.21) | 89.8 | 62.1 | - |
| ≤ 6 | 1.28 (1.07-1.53) | 9.2 | 22.5 | - |
| > 6 | 1.00 | 1.0 | 15.4 | - |
| BMI < 25 | 1.00 | 74.1 | 71.2 | - |
| BMI ≥ 25 | 1.40 (1.02-1.53) | 25.9 | 28.8 | - |
| No | 1.00 | 67.3 | 53.5 | - |
| Yes | 1.15 (0.72-2.66) | 32.7 | 46.5 | - |
| Never | 1.00 | - | 84.3 | 84.3 |
| Ever | 1.31 (1.04-1.64) | - | 15.7 | 15.7 |
| Never | 1.00 | - | 97.5 | 96.6 |
| Ever | 1.16 (0.36-3.87) | - | 2.5 | 3.4 |
This study assumed a latency period of about 15 years between the exposure of a risk factor and breast cancer development, except for oral contraceptive (OC) and hormone replacement therapy (HRT) use. We assumed the annual increasing rates for the future prevalence rates of OC and HRT use to be 0% and 2%, respectively, considering the trend for OC and HRT use during 2001-2015. CI, confidence interval; BMI, body mass index.
Fig. 3.Projected disability-adjusted life years (DALYs), years of life lost (YLL), and years lived with disability (YLD) trends of breast cancer in Korean women from 1999 to 2030.
Fig. 4.Projected burden of breast cancer attributable to lifestyle changes (disability-adjusted life years [DALYs] per 100,000 women).